3 buy-rated ASX growth shares tipped to rise 30% to 125%

Brokers expect big returns from these shares over the next 12 months.

Do you want to buy some ASX growth shares for your portfolio? If you do, then it could be worth checking out the three named below that analysts are bullish on.

Here's what they are recommending to clients:

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company

Image source: Getty Images

Life360 Inc. (ASX: 360)

One company that continues to build momentum is Life360. It is best known for its family safety app, which allows users to track the location of loved ones and receive alerts related to driving behaviour, emergencies, and device safety.

While the app originally focused on location sharing, Life360 has gradually expanded its platform to include a range of subscription services such as roadside assistance, identity protection, and emergency response features.

The strength of the business lies in its growing global user base. Millions of families now rely on the platform daily, which gives the company opportunities to increase monetisation through premium subscriptions and additional services.

With the business moving toward stronger profitability and expanding its product ecosystem, Life360 has the potential to continue growing strongly over time.

This week, Bell Potter put a buy rating and $40.00 price target on its shares. This implies potential upside of 85% for investors over the next 12 months.

Pro Medicus Ltd (ASX: PME)

Another ASX growth share worth watching is Pro Medicus.

The healthcare technology company develops advanced medical imaging software used by hospitals and radiology groups around the world.

Its Visage platform allows radiologists to view complex scans quickly and efficiently, which improves productivity and patient outcomes.

What makes Pro Medicus particularly interesting is its success in winning long-term contracts with large hospital networks in the United States. These deals often run for several years and can generate significant recurring revenue.

As global demand for medical imaging continues to grow, Pro Medicus appears well placed to keep expanding its footprint internationally.

Morgans has a buy rating and $275.00 price target on its shares. This suggests that its shares could rise 125% between now and this time next year.

REA Group Ltd (ASX: REA)

A final ASX growth share that continues to impress is REA Group.

REA operates realestate.com.au, the dominant online property marketplace in Australia. The platform has become the go-to destination for Australians searching for homes, rental properties, and real estate data.

Its strong market position allows the company to charge real estate agents premium prices for listings and advertising products. This has helped REA deliver consistently strong earnings growth over many years.

Beyond Australia, the company also has investments in international property portals, which provide additional growth opportunities.

With Australia's property market remaining highly active and digital advertising continuing to evolve, REA Group still appears well positioned for long-term expansion.

UBS has a buy rating and $218.90 price target on REA Group's shares. This implies potential upside of over 30% for investors over the next 12 months.

Motley Fool contributor James Mickleboro has positions in Life360, Pro Medicus, and REA Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Coins in ascending order from left to right, with a piggy bank and clock on the sides.
Growth Shares

2 top ASX shares to buy and hold for the next decade

These two investments have incredible long-term outlooks.

Read more »

Rocket going up above mountains, symbolising a record high.
Growth Shares

2 ASX shares tipped to grow 100% or more in the next 12 months

These two stocks could deliver massive returns.

Read more »

Smiling woman pointing at rising graph.
Growth Shares

2 strong Australian stocks to buy now with $9,000

These stocks look like top buys to me right now.

Read more »

Wooden house and golden coins on balancing scale.
Growth Shares

Is the REA Group share price a strong contrarian buy?

Is this a good time to invest in the property portal business?

Read more »

Ascending piles of coins and plants in three jars, with a hand putting a coin in the first jar.
Growth Shares

A rare buying opportunity in 1 of Australia's top shares?

This stock is an ASX leader and it looks like one of Australia’s top shares.

Read more »

Two smiling colleagues looking at a tablet in a data centre.
Growth Shares

Will Goodman shares reach $30 in 2027?

I look at the earnings forecasts to see how realistic a move back to this level could be.

Read more »

Two brokers analysing the share price with the woman pointing at the screen and man talking on a phone.
Growth Shares

2 ASX shares highly recommended to buy: Experts

These businesses could be undervalued and deliver good returns.

Read more »

Woman pointing to a hologram of a world map with finance graphs and related themes.
Growth Shares

Down over 50%: 2 ASX shares to buy for global growth

Both companies are building global momentum. Patient investors should watch.

Read more »